Cargando…
Evaluation of Mizoribine as an Immunosuppressant in Subrenal Capsule Assay Using Immunocompetent Mice
We studied the application of mizoribine (MZR) to normal immunocompetent mice in subrenal capsule assay (SRCA) by means of tumor growth curve determination, histological analysis and autoradiography. At 400 mg/kg, MZR prolonged the actual tumor growth and moderately reduced the host reaction. Doses...
Autores principales: | Chen, Dong‐Yi, Kikuchi, Hiroaki, Asamura, Mitsuo, Gamoh, Makio, Wakui, Akira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1990
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5963903/ https://www.ncbi.nlm.nih.gov/pubmed/2110133 http://dx.doi.org/10.1111/j.1349-7006.1990.tb02546.x |
Ejemplares similares
-
Subrenal capsule assay in selection of chemotherapy after operation for recurrent ovarian cancer.
por: Venesmaa, P., et al.
Publicado: (1991) -
The 6 day subrenal capsule assay is of no value with primary surgical explants from gastric cancer.
por: Cunningham, D., et al.
Publicado: (1986) -
Subrenal Capsule Assay - SRCA: The Promising Re-Emergence of a Long-Forgotten Method in Preclinical Nuclear Medical Cancer Diagnostics
por: Képes, Zita, et al.
Publicado: (2023) -
Radiation Responses of Subrenally Transplanted Syngeneic and Allogeneic Mouse Fibrosarcomas
por: Sato, Setsu, et al.
Publicado: (1988) -
The Immunosuppressive Agent Mizoribine Monophosphate Is an Inhibitor of the Human RNA Capping Enzyme
por: Picard-Jean, Frédéric, et al.
Publicado: (2013)